The psychostimulant dlmethylphenidate (MPH) remains the most common drug therapy in
child and adolescent psychiatry for the treatment of attentiondeficithyperactivity disorder …

Background There is increasing concern that prescription stimulants may be associated with
adverse cardiovascular events such as stroke, myocardial infarction, and sudden death …

However, an obesity-related increase in BP has not been documented in all studies. In the
Bogalusa Heart Study, which used the mean of 6 resting BP measurements instead of 2 or 3 …

Objective To determine whether treatment with methylphenidate in children and young
people with attention-deficit/hyperactivity disorder (ADHD) was associated with …

Monitoring the safety of medicine use in children is of paramount importance since during
the clinical development of medicines only limited data on this aspect are generated through …

OBJECTIVES. Case reports have raised concerns about the risk of cardiac events
associated with central nervous system stimulants for the treatment of attention …

Millions of children with attention deficit hyperactivity disorder (ADHD) are treated with
stimulant medications. To evaluate cardiovascular risk, 24-h ambulatory blood pressure …

Objective: It is unknown whether prolonged childhood exposure to stimulant medication for
the treatment of attention deficit hyperactivity disorder (ADHD) increases the risk for …

Rationale The cardiovascular effects of psychostimulant drugs (methylphenidate,
amphetamine, cocaine) have been mostly associated with their noradrenergic effects …

Objective: The objective of this fixed-dose study was to determine the efficacy and safety of a
new formulation of modafinil (modafinil film-coated tablets) in children and adolescents with …